Not Tagged
Not Tagged
['hodgkin', 'car t', 'lymphoma']
new trial in progress data from a phase 1/2 trial evaluating bbt369, a dual targeting car t-cell product with a gene edit, for relapsed/refractory b-cell non-hodgkin #lymphoma. check out 's poster #231b tomorrow morning at #asco22. 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.